Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China Biologic Reports Financial Results for the First Quarter of 2019 2019-05-11 04:30
EnGeneIC Announces First Patients with Advanced-Stage Pancreatic Cancer Dosed in Phase 1/2a Clinical Study of Targeted Cytotoxic Immunotherapy 2019-05-10 05:05
GeneQuantum Healthcare completed nearly RMB 100 million in Pre-B financing 2019-05-08 08:00
MEDI FUTURES Signs MOU with Soonchunhyang University Hospital Bucheon for Clinical Research 2019-05-03 20:30
Samsung BioLogics signs CDO(Contract Development Organization) contract with GI Innovation 2019-05-03 14:36
China Biologic Products to Report First Quarter 2019 Financial Results 2019-04-30 20:00
GC Pharma Reports Q1 2019 Results 2019-04-30 15:37
New Research Partnership Brings Top-Class Scientists to China to Tackle Biomedical Problems 2019-04-26 18:33
Specialisterne Foundation and Brunel Enable Autistic People to Join the Workforce 2019-04-25 09:00
HEC TaiGen Initiates Phase III Trial of Combination of Furaprevir and Yimitasvir for the Treatment of Chronic Hepatitis C Patients in China 2019-04-23 15:58
ACT Genomics Establishes NGS Laboratory to Offer Comprehensive Cancer Genomic Profiling Service in Japan 2019-04-19 12:00
Senhwa Biosciences Silmitasertib / Basal Cell Carcinoma Trial Completed 1st Patient Enrollment 2019-04-17 19:00
Wuhan Lays Out Construction of Guanggu Nanda Health Industrial Park 2019-04-12 14:06
I-Mab Biopharma Signs Agreement for Clinical Research of TJD5 in Combination Therapy 2019-04-11 10:34
Antengene Corporation Announces Establishment of U.S. Subsidiary and Collaboration with the Baruch S. Blumberg Institute 2019-04-08 20:00
WuXi AppTec Appoints Dr. Frederick H. Hausheer as Chief Medical Officer 2019-04-08 10:00
WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection 2019-03-27 14:00
Dr Thomas Ramdahl Joins Clarity Pharmaceuticals' Board 2019-03-26 08:30
WuXi AppTec Reports Strong 2018 Annual Results 2019-03-22 20:47
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials 2019-03-21 18:21
1 131 132 133 134 135 222